NIH-funded research U01 cooperative agreement

Gut-brain connections in Parkinson’s disease: how the gut and environment shape symptoms

Official title: Mayo Clinic Consortium for Gut Brain Communication in Parkinson's Disease

Funded at Mayo Clinic Rochester · NIH-11596497 · Data updated 2026-11-12

A Mayo Clinic team is studying how gut problems, environmental factors, and genetics together influence Parkinson’s disease and its GI symptoms to find biomarkers and better understanding of the disease.

More s Disease research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionMayo Clinic Rochester
NIH-funded
Lab location1 site (Rochester, United States)
Project startSeptember 1, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$200,000
NIH project number3U01DK140921-03S1
Project IDNIH-11596497 on NIH RePORTER

Who could benefit from this research

Could help

People with Parkinson’s disease who have constipation (PwPD-C), people with Parkinson’s without constipation (PwPD-noC), and healthy controls.

Less likely to help

Individuals without Parkinson’s disease or related GI symptoms may not directly benefit.

What this research studies

This project looks at how gut health, brain function, and environmental exposures interact in people with Parkinson’s, including those with constipation and those without. Researchers will compare brain-gut interactions, analyze omics-based disease signatures, and study environmental exposures in three groups: people with Parkinson’s who have constipation, Parkinson’s without constipation, and healthy controls. Using imaging, tissue samples, and data from multiple disciplines, they aim to map how these factors come together to drive the disease process. The ultimate goal is to identify biomarkers and pathways that could inform future patient care and monitoring.

Why it matters

Potential benefit: If successful, patients could benefit from better understanding of gut-related symptoms, biomarkers for early detection, and more personalized approaches to managing Parkinson’s disease.

How similar studies have gone: Previous work has linked gut dysfunction and inflammation to Parkinson’s, with growing evidence supporting gut-brain connections, though comprehensive biomarker and exposome profiling is still emerging.

Where this research is happening

  • Mayo Clinic Rochester
    Rochester, United States
    Active

Researchers

  • Principal investigator: Bharucha, Adil E. — Mayo Clinic Rochester
  • Study coordinator: Bharucha, Adil E.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.